Search

Your search keyword '"Torre I."' showing total 316 results

Search Constraints

Start Over You searched for: Author "Torre I." Remove constraint Author: "Torre I." Database Unpaywall Remove constraint Database: Unpaywall
316 results on '"Torre I."'

Search Results

1. AB1553-HPR BASELINE CHARACTERISTICS OF PATIENTS WITH SLE ACROSS 5 REGISTRIES – THE LUPUSNET FEDERATED DATA NETWORK

3. AB1283 ROLE OF IL-17A IN GIANT CELL ARTERITIS: POTENTIAL USEFULNESS AS A BIOMARKER FOR DISEASE ACTIVITY

4. POS0114 LUPUS NEPHRITIS AND RESPONSE TO TREATMENT IN LATIN AMERICA

6. Guidelines for Overcoming the Practical Limitations for the Fabrication of THz Sources with GaN Planar Gunn Diodes

12. Efficacité et arrêts de traitement sous baricitinib dans la polyarthrite rhumatoïde selon l’âge du patient et le traitement antérieur: données sur 2 ans issues de la cohorte européenne de l’étude RA-BE-REAL

16. POS0273 POST COVID-19 SYNDROME IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: RESULTS FROM THE COVAD STUDY

17. AB0580 PREGNANCY OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): DATA FROM A MULTIETHNIC, MULTINATIONAL LATIN AMERICAN COHORT

18. AB0829 PROGRESSION OF ILD (INTERSTITIAL LUNG DISEASE) IN PFT (PULMONARY FUNCTION TEST) AND HRCT (HIGH RESOLUTION COMPUTERIZED TOMOGRAPHY) ACCORDING TO CTD (CONNECTIVE TISSUE DISEASE) IN 12 MONTHS

19. POS0169 PREDICTORS OF FIRST HOSPITALIZATIONS DUE TO DISEASE ACTIVITY AND INFECTIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

20. POS0848 DISCONTINUATION AND EFFECTIVENESS OF BARICITINIB IN RHEUMATOID ARTHRITIS ACCORDING TO PATIENT AGE AND PRIOR TREATMENT: 2-YEAR DATA FROM THE EUROPEAN COHORT OF THE RA-BE-REAL STUDY

21. AB1788-HPR ASYNCHRONOUS TELECONSULTATION BY WHATSAPP CHATBOT IN CONTROLLED AXIAL SPONDYLOARTHRITIS PATIENTS UNDER BIOLOGICAL THERAPY: PATIENTS’ PERSPECTIVE

24. FAB10: a user-oriented bandwidth-tunable extreme ultraviolet lightsource for investigations of femtosecond to attosecond dynamics in gas and condensed phases

26. Microbiological surveillance post-reprocessing of flexible endoscopes used in digestive endoscopy: a national study

27. Efficacité et tolérance du baricitinib chez des patients atteints de lupus érythémateux systémique : résultats de deux études de phase 3, en double insu, randomisées versus placebo

32. PO.1.10 Multicentre study in sle patients with and without renal involvement by label free proteomic analysis of 24h urine

34. AB0266 PREGNANCY PLANNING AND FOLLOW-UP IN MULTIDISCIPLINARY UNITS IMPROVES THE OUTCOMES IN WOMEN WITH INFLAMMATORY ARTHROPATHIES

35. POS0190 EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM TWO RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDIES

36. AB0676 One year progression of interstitial lung disease in connective tissue diseases. A descriptive study in a single tertiary center.

37. POS0712 YEAR-4 OBSERVATIONAL FOLLOW-UP OF BELIMUMAB SAFETY (MORTALITY AND MALIGNANCIES) IN PATIENTS WITH SLE WHO COMPLETED A PHASE 4, 52-WEEK, RANDOMISED, DOUBLE-BLIND PLACEBO-CONTROLLED SAFETY STUDY

40. POSA370 Healthcare Resource Use By European Patients Enrolled in RA-be-Real: A Multinational, Prospective, Observational Study of the Effectiveness, Healthcare Resource Utilization and Costs in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic or Biologic Disease Modifying Therapies

43. Étude internationale, observationnelle et prospective chez des patients atteints de PR recevant du baricitinib, des csDMARD ou bDMARD (RA-BE-REAL): schéma de l’étude et caractéristiques des patients à l’inclusion

44. Étude internationale, observationnelle et prospective chez des patients atteints de PR recevant du baricitinib, des csDMARD ou bDMARD : efficacité à 6 mois et résultats des mesures rapportées par les patients (PRO) de la cohorte européenne

Catalog

Books, media, physical & digital resources